A public health crisis related to substance use disorder is evident in the United States, marked by a surge in cases since the COVID-19 pandemic and a decline in treatment due to disrupted healthcare services. However, rates of people receiving treatment began improving in 2022, likely due to the reopening of programs and an increased use of telehealth services.
“These results call for urgent interventions to bridge the gap between the need for and receipt of SUD treatment, especially after the pandemic. Effective strategies should include enhancing access to counseling services, expanding insurance coverage for treatments, raising public awareness through targeted campaigns, and integrating SUD care into primary healthcare settings,” the authors wrote.
The examination led Ligang Liu, PharmD, of the Institute of Inventions and Effects at Ohio State University’s Healing Institute of the University of Ohio in Columbus, Ohio. Posted online January 6, 2025, on JAMA Network Open.
Auto -informed knowledge dependence on a primary limitation of this study.
No investment source for this study has been informed. The authors have declared any clash of applicable interests.
This article was created several editorial tools, adding AI, as a process component. Human editors reviewed this content before the publication.
Send comments and news to News@medscape. net.